Notice is hereby given that the Office of Research Integrity (ORI) has made final findings of scientific misconduct in the following case: Eric T. Fossel, Ph.D., Harvard Medical School: Based on ORI\'s analysis of the relevant evidence and conclusions submitted by the Harvard Medical School Committee on Faculty Conduct, ORI found that Eric T. Fossel, Ph.D., former Harvard Medical School Associate Professor of Radiology at Beth Israel Hospital, committed scientific misconduct by reporting falsified research results in a Public Health Service (PHS) grant application. Specifically, Dr. Fossel altered nuclear magnetic resonance (NMR) data in the Multicenter Breast Trial (MCBT) such that the NMR test, purporting to detect from a patient\'s blood sample a predisposition toward malignancy or a relapse, appeared to be more accurate, sensitive, and specific than was actually the case. Premised on these falsely reported results, Dr. Fossel proposed in a PHS grant application that the National Cancer Institute provide funds to complete the MCBT. Dr. Fossel has entered into a Voluntary Exclusion Agreement with ORI in which he has voluntarily agreed, for the three (3) year period beginning May 9, 1996, to exclude himself from: (1) any contracting or subcontracting with any agency of the United States Government and from eligibility for, or involvement in, nonprocurement transactions (e.g., grants and cooperative agreements) of the United States Government as defined in 45 CFR Part 76 (Debarment Regulations), and (2) serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. No scientific publications were required to be corrected as part of this Agreement.
